Institut Marquès IVF Centre Expands To Abu Dhabi With Ethmar International Holding

Ethmar International Holding is forming a partnership with FutureLife group to open an Institut Marquès assisted reproductive technology centre in Abu Dhabi by 2026. The project aims to support the emirate’s role as a global healthcare hub and expand access to advanced fertility treatments for local, regional and international patients.

The move comes as infertility affects around one in six adults worldwide, according to the World Health Organisation. By adding a specialised fertility centre, Abu Dhabi will widen its medical tourism offer and strengthen high-value healthcare services, which remain priorities within the emirate’s long-term health strategy and wider economic agenda.

Institut Marquès has more than 100 years of history in assisted reproduction and is recognised for strong success rates in in vitro fertilisation. The organisation operates advanced embryology laboratories and applies multidisciplinary care, with about 200 professionals, including gynaecologists, embryologists and psychologists, supporting patients throughout treatment.

The provider reports IVF success rates reaching up to 86 percent, placing Institut Marquès among the leading clinics internationally. Existing centres are located in Barcelona, Sabadell, Rome and Milan. The Abu Dhabi facility will transfer this European clinical experience and technology to the UAE, while aligning with local regulations and national healthcare objectives.

The new assisted reproductive technology centre will be embedded within Abu Dhabi’s healthcare ecosystem, working under the emirate’s regulatory framework and quality standards. Patients are expected to receive a full range of fertility services, from diagnosis to advanced treatment, supporting both residents and visitors seeking care in the UAE capital.

Key operational details for Institut Marquès are outlined below.

EIH stated that the partnership supports Abu Dhabi’s wider ambitions for healthcare leadership. EIH said, "Access to effective fertility remains a significant global challenge. By bringing Institut Marquès to Abu Dhabi, EIH is underscoring its commitment to supporting the emirate’s ambition to become a regional and global healthcare hub. The strength and legacy of Institut Marquès in Europe demonstrate its scalability, clinical governance and ability to deliver consistently across multiple markets."

Institut Marquès forms part of FutureLife group, which operates more than 60 reproductive medicine clinics across 16 countries. Abu Dhabi is expected to function as the platform for Institut Marquès’ regional growth in the Middle East, highlighting the city’s role in specialised reproductive care and reinforcing its profile among international healthcare investors.

FutureLife group receives backing from Hartenberg and CVC Capital Partners. Hartenberg focuses on investment growth and long-term value creation, while CVC Capital Partners has an established record of investing in the UAE. CVC Capital Partners plans to continue supporting businesses that contribute to the country’s development, which includes the assisted reproductive technology expansion with Ethmar International Holding and Institut Marquès.

With inputs from WAM